Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03680703 · ClinicalTrials.gov registry record · NA
Bariatric Scalable Internet Treatments
A NA study of Weight Loss and Bariatric Surgery, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT03680703: Completed NA study of Weight Loss and Bariatric Surgery, sponsored by Yale University.
NCT03680703 is a NA study of Weight Loss and Bariatric Surgery that has completed, run by Yale University. The registered enrollment target is 33 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03680703, a NA study of Weight Loss and Bariatric Surgery, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to conduct a randomized clinical trial examining the feasibility and effectiveness of two guided self-help behavioral weight loss (gshBWL) treatments delivered via the internet for individuals struggling with weight loss one year following bariatric surgery. The two treatments will consist of 1) gshBWL delivered through the internet only (gshBWL-I) and 2) gshBWL delivered via the internet with additional complementary phone sessions (gshBWL-IP).
Primary Outcome
Percent weight loss (in pounds) from baseline.
Conditions Studied
Interventions
- BEHAVIORAL Guided Self-Help Behavioral Weight Loss
Study Locations (1)
Connecticut
- Yale Department of Psychiatry - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2018-07-20 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT03680703 record still lists
NCT03680703 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Weight Loss appearing as the primary indexed condition, and to 1 intervention - of which Guided Self-Help Behavioral Weight Loss is the first listed.
NCT03680703 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03680703 about?
NCT03680703 is a clinical study titled "Bariatric Scalable Internet Treatments". The purpose of the study is to conduct a randomized clinical trial examining the feasibility and effectiveness of two guided self-help behavioral weight loss (gshBWL) treatments delivered via the internet for individuals struggling with weight loss one year following bariatric surgery. The two treat...
What is the current status of trial NCT03680703?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2018-07-20. Estimated completion is 2019-12-31.
What conditions does trial NCT03680703 study?
This clinical trial studies the following conditions: Weight Loss, Bariatric Surgery.
What interventions are being tested in trial NCT03680703?
The interventions under investigation include: Guided Self-Help Behavioral Weight Loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT03680703?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03680703 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03680703's enrollment target sits among peer trials
33 95th of 116 higher than 22 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI